Want to join the conversation?
$XRX 2Q15 Call: Our cash balance at end of quarter was $1.6Bil, an increase of $769MM since end of first quarter, driven by the proceeds received on June 30th from the ITO divestiture. We ended second quarter with $7.6Bil debt; & our allocated financing debt at end of second quarter was $3.9Bil, leaving core debt at $3.7Bil.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)